adducts, intra- and interstrand cross-links) and the desired
ICLs usually make up only a small fraction (typically 1-5%)
of all the products formed. More efficient approaches to the
chemical synthesis of ICLs have subsequently been devel-
oped. One was based on the cross-linking of nucleosides
outside of DNA followed by incorporation of the cross-linked
dimer into DNA using solid-phase synthesis.9 This approach
has been particularly successful in yielding ICLs that connect
two bases through their Watson-Crick faces, although the
solid-phase synthesis procedures are complicated by the
connected nucleoside dimers. A second approach consists
of the site-specific incorporation of postsynthetically modifi-
able cross-link precursors on one or two opposing strands
of DNA, annealing of the two single strands and subsequent
use of a specific coupling reaction to generate the ICL. This
concept has been used in the synthesis of ICLs containing
disulfide, psoralen, malondialdehyde, and alkyl linkages.10,11
With the exception of disulfide ICLs, there has been a lack
of efficient syntheses of ICLs formed in the major groove
of DNA, where adducts by the clinically most important ICL-
forming agents including the nitrogen mustards (NMs) are
formed.
NMs preferentially form ICLs between the N7 positions
of dG residues in a 5′-GNC sequence context and introduce
a slight distortion into the DNA.6,7,12,13 Following the initial
pioneering studies of NM ICLs by the Loechler and Hopkins
groups, no further efforts toward high-yielding synthesis of
these adducts have been reported.6
We designed a strategy for the synthesis of NM ICL
mimics 2 based on the incorporation of ICL precursor
nucleosides on opposing strands of DNA and the use of a
subsequent specific coupling reaction to establish the ICL
(Figure 1). We reasoned that alkylamine-containing cross-
links may be accessed by a double-amination reaction from
two aldehyde groups (3) on cDNA strands using an ap-
propriate amine. Since guanine bases alkylated at the 7
position in the native NM ICL 1 are prone to depurination
Figure 1. Structures of NM ICLs 1 and strategy for the synthesis
of NM ICL analog 2. NM ICLs (1) connect two complementary
DNA strands by connecting two guanine bases through the N(7)
positions. Our target NM ICL mimic 2 has the nitrogen at the 7
positions replaced with carbon to render the glycosidic bond of
the ICL stable for synthesis and functional studies (X ) amine-
containing compound). We envisioned that ICL 2 could be obtained
via double-reductive amination of an aldehyde 3 with an appropriate
amine, XH. 3 in turn could be derived from phosphoramidite 4,
where the aldehyde is masked as a protected diol.
due to the positive charge on nitrogen, we decided to pursue
the synthesis of the more stable, isosteric 7-deaza analogues
2. The increased hydrolytic stability of the 7-deaza com-
pounds should make it possible to incorporate them into
DNA using solid-phase synthesis and make them attractive
substrates for biological studies. We envisioned that the
aldehyde would be introduced into DNA masked as a
protected diol 4,14 using standard phosphoramidite chemistry
(Figure 1).
The synthesis of 4 (Scheme 1) started with 6-chloro-7-
deaza-3′,5′-di-O-p-toluoyl-2′-deoxyguanosine 5,15 which was
protected as an isobutyric amide at the N(2) position and
selectively iodinated at C(7).16 A Stille coupling reaction
was then used to introduce the allyl group in 6. Treatment
with pyrimidine-2-carboxaldoxime17 restored the deazagua-
nine core, and the toluoyl protecting groups in the carbo-
hydrate moiety were replaced with TBDMS. The allyl group
of 7 was then oxidized to corresponding diol (8) using
osmium tetroxide, and the newly generated hydroxyl groups
were protected as acetate esters. Finally, the TBDMS
protecting groups were removed, and the sugar moiety was
elaborated to the phosphoramidite 4 using standard proce-
dures.
(6) Ojwang, J. O.; Grueneberg, D. A.; Loechler, E. L. Cancer Res. 1989,
49, 6529–37. Millard, J. T.; Raucher, S.; Hopkins, P. B. J. Am. Chem. Soc.
1990, 112, 2459–2460.
(7) Rink, S. M.; Solomon, M. S.; Taylor, M. J.; Rjur, S.; McLaughlin,
L. W.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 2551–2557.
(8) Warren, A. J.; Hamilton, J. W. Chem. Res. Toxicol. 1996, 9, 1063–
71. Fischhaber, P. L.; Gall, A. S.; Duncan, J. A.; Hopkins, P. B. Cancer
Res. 1999, 59, 4363–8.
(9) Harwood, E. A.; Sigurdsson, S. T.; Edfeldt, N. B. F.; Reid, B. R.;
Hopkins, P. B. J. Am. Chem. Soc. 1999, 121, 5081–5082. Li, H. Y.; Qiu,
Y. L.; Moyroud, E.; Kishi, Y. Angew. Chem., Int. Ed. Engl. 2001, 40, 1471–
1475. Noll, D. M.; Noronha, A. M.; Miller, P. S. J. Am. Chem. Soc. 2001,
123, 3405–11. Wilds, C. J.; Noronha, A. M.; Robidoux, S.; Miller, P. S.
J. Am. Chem. Soc. 2004, 126, 9257–9265. Wilds, C. J.; Xu, F.; Noronha,
A. M. Chem. Res. Toxicol. 2008, 21, 686–95.
Using solid-phase synthesis, 4 was incorporated into two
cDNA strands as a part of a 5′-d(GNC) sequence (10a-d,
Figure 2A), which has been shown to be the preferred site
for NM ICL formation.7 The two single-stranded oligonucle-
otides were purified by solid phase extraction using TOP-
(10) Ferentz, A. E.; Keating, T. E.; Verdine, G. L. J. Am. Chem. Soc.
1993, 115, 9006–9014. Erlanson, D. A.; Chen, L.; Verdine, G. L. J. Am.
Chem. Soc. 1993, 115, 12583–12584. Kobertz, W. R.; Essigmann, J. M.
J. Am. Chem. Soc. 1997, 119, 5960–5961. Dooley, P. A.; Tsarouhtsis, D.;
Korbel, G. A.; Nechev, L. V.; Shearer, J.; Zegar, I. S.; Harris, C. M.; Stone,
M. P.; Harris, T. M. J. Am. Chem. Soc. 2001, 123, 1730–9. Hong, I. S.;
Greenberg, M. M. J. Am. Chem. Soc. 2005, 127, 10510–1. Hong, I. S.;
Greenberg, M. M. J. Am. Chem. Soc. 2005, 127, 3692–3
.
(14) Khullar, S.; Varaprasad, C. V.; Johnson, F. J. Med. Chem. 1999,
42, 947–50.
(11) Alzeer, J.; Scha¨rer, O. D. Nucleic Acids Res. 2006, 34, 4458–66
.
(12) Rink, S. M.; Hopkins, P. B. Biochemistry 1995, 34, 1439–45. Dong,
Q.; Barsky, D.; Colvin, M. E.; Melius, C. F.; Ludeman, S. M.; Moravek,
J. F.; Colvin, O. M.; Bigner, D. D.; Modrich, P.; Friedman, H. S. Proc.
(15) Seela, F.; Westermann, B.; Binding, U. J. Chem. Soc., Perkin Trans.
1 1988, 697–702.
(16) Ramzaeva, N.; Seela, F. HelV. Chim. Acta 1995, 78, 1083–1090.
(17) Buhr, C. A.; Wagner, R. W.; Grant, D.; Froehler, B. C. Nucleic
Acids Res. 1996, 24, 2974–80.
Natl. Acad. Sci. U.S.A. 1995, 92, 12170–4
.
(13) Fan, Y.-H.; Gold, B. J. Am. Chem. Soc. 1999, 121, 11942–11946
.
662
Org. Lett., Vol. 11, No. 3, 2009